ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 725048 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 725048; 2) Community: the network communities that were significantly associated with the response to NSC 725048; 3) Molecule: the relationships between components within communities and NSC 725048; 4) MDR: the compounds that were significantly associated with the NSC 725048.

NSC Compound Enrichment Correlation
NSC 648265 [3-keto-Bmt(sup 1)]-[Val(sup 2)]-Cyclosporin 0.0102077332082017 0.19422077
NSC 664993 Null 0.0102077332082017 0.31520329
NSC 673421 Null 0.0102077332082017 0.3508752
NSC 678049 Null 0.0102077332082017 0.23334558
NSC 702015 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- 0.0102077332082017 0.32591727
NSC 705928 Null 0.0102077332082017 0.55883094
NSC 708422 Null 0.0102077332082017 0.22639289
NSC 709971 7H-Thieno[3',4':3,4]cyclopent[1,2-d]oxazol-7-one, 4,6-dibromo-1,2,3a,7a-tetrahydro-2-thioxo-, CIS- 0.0102077332082017 0.61508449
NSC 301457 Cycloalkannin 0.0112341530780143 0.55914034
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0112341530780143 0.66168239
Total:104  Current:32    [First] [Prev] [Next] [Last]